tickrz reports
  
tickrz rank
A
DaVita HealthCare Partners Inc (DVA)
Healthcare | Specialized Health Services
CEO: Kent J. Thiry
Employees: 60400
davita.com
FACTOR RANKINGSFACTOR SCREENER 
Pure Value Rank32Dividend RankNO DIVIDEND
Moat Rank289Financial Strength Rank246
Growth Rank43Momentum Rank460
DIVIDEND ANALYSIS
Dividend Yield0%
Payout Ratio14.57%
3 yr Dividend GrowthN/A
VALUATION RATIOS
P/E Ratio10.25x
P/B Ratio2.45x
P/S Ratio0.82x
EV/EBITDA Ratio6.46x
FINANCIAL STRENGTH
Piotroski F-Score7
Debt-to-Equity144%
Interest Coverage5.84x
MOAT
ROE22.96%
ROIC12.73%
Net Margin5.97%
GROWTH
5 yr EPS Growth11.39%
5 yr SPS Growth16.13%
5 yr BPS Growth15.88%
tickrz A-Ranked DaVita HealthCare Partners Inc scores well on valuation
 tickrz summary
DaVita HealthCare Partners Inc receives an A ranking in our proprietary multi-factor ranking approach that blends valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.
 value
 pure value ranking Warren Buffett ranking
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. DaVita HealthCare Partners Inc's valuation score is comprised of a P/E ratio of 10.3x, a P/B ratio of 2.5x, a P/S ratio of 0.8x, and an EV/EBITDA ratio of 6.5x. DaVita HealthCare Partners Inc ranks 32 out of the S&P 500 constituents on valuation--a relatively strong score.DaVita HealthCare Partners Inc ranks 56 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, DaVita HealthCare Partners Inc warrants further investigation.

 quality
 moat financial strength
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is average. Our analysis of its moat reveals neither a durable moat or enduring competitive advantages.DaVita HealthCare Partners Inc has a Piotroski F Score of 7 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 5.84x, a debt/equity ratio of 144% and a Moat Rank of 289 translate to an average Financial Strength score.


 momentum
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors.The company has seen its stock fall by -12.37% over the last 12 months. This performance is weak compared to other stocks in the S&P 500, earning it a rank of 460. Based on its 12 month stock performance, DaVita HealthCare Partners Inc will not appeal to momentum investors.

 yield
 value + yield
DaVita HealthCare Partners Inc currently does not pay a dividend so it ranks last among S&P 500 companies using our dividend ranking methodology. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

 growth
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the top third of S&P 500 companies. Its 11.4% 5 year annualized EPS growth, 16.1% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 15.9% speak to its impressive growth ranking.

DaVita HealthCare Partners Inc (DVA)
Healthcare | Specialized Health Services
CEO: Kent J. Thiry
Employees: 60400
davita.com


tickrz rank
A

VALUATION RATIOS
P/E Ratio10.25x
P/B Ratio2.45x
P/S Ratio0.82x
EV/EBITDA Ratio6.46x
DIVIDEND ANALYSIS
Dividend Yield0%
Payout Ratio14.57%
3 yr Dividend GrowthN/A
FINANCIAL STRENGTH
Piotroski F-Score7
Debt-to-Equity144%
Interest Coverage5.84x
MOAT
ROE22.96%
ROIC12.73%
Net Margin5.97%
GROWTH
5 yr EPS Growth11.39%
5 yr SPS Growth16.13%
5 yr BPS Growth15.88%

TICKRZ RANK
DaVita HealthCare Partners Inc receives an A ranking in our proprietary multi-factor ranking approach that blends valuation, moat, operational performance, and financial strength. View the Top 50 tickrz ranked stocks here.

PURE VALUE
Valuation is the most heavily weighted component in our tickrz ranking methodology. Numerous academic and practitioner studies have found that a value approach outperforms the market over the long-run. DaVita HealthCare Partners Inc's valuation score is comprised of a P/E ratio of 10.3x, a P/B ratio of 2.5x, a P/S ratio of 0.8x, and an EV/EBITDA ratio of 6.5x. DaVita HealthCare Partners Inc ranks 32 out of the S&P 500 constituents on valuation--a relatively strong score.

WARREN BUFFETT RANKING
DaVita HealthCare Partners Inc ranks 56 out of the S&P 500 constituents in our multi-factor Warren Buffett ranking methodology. This is a strong score, meaning it ranks highly on valuation, moat, volatility, and financial strength factors. If you're looking for undervalued stocks with high moats and strong competitive advantages, DaVita HealthCare Partners Inc warrants further investigation.

MOAT
To calculate a company's Moat Score, we look at its historical earnings growth, historical average return on equity, the volatility of its earnings stream, and also factor in the strength of its balance sheet. Our approach concludes the company's business moat is average. Our analysis of its moat reveals neither a durable moat or enduring competitive advantages.

FINANCIAL STRENGTH
DaVita HealthCare Partners Inc has a Piotroski F Score of 7 out of 9. The F Score examines changes in profitability, leverage, liquidity, and operating efficiency. Interest coverage of 5.84x, a debt/equity ratio of 144% and a Moat Rank of 289 translate to an average Financial Strength score.

MOMENTUM
Investment research has shown that stocks with strong performance over the last 6 to 12 months tend to perform better in the medium term than stocks with poor performance over the same period. In fact, the momentum factor is one of the strongest of all the investment factors.The company has seen its stock fall by -12.37% over the last 12 months. This performance is weak compared to other stocks in the S&P 500, earning it a rank of 460. Based on its 12 month stock performance, DaVita HealthCare Partners Inc will not appeal to momentum investors.

VALUE + YIELD
DaVita HealthCare Partners Inc currently does not pay a dividend so it ranks last among S&P 500 companies using our dividend ranking methodology. Investors looking for undervalued dividend stocks will probably want to look elsewhere.

GROWTH
A company's growth metrics are less important than its valuation, moat, and financial strength. However, a check on growth can be a good way to avoid companies in secular decline. The company's growth in sales, earnings, and book value places it among the top third of S&P 500 companies. Its 11.4% 5 year annualized EPS growth, 16.1% 5 year annualized sales-per-share growth, and 5 year annualized book value-per-share growth of 15.9% speak to its impressive growth ranking.